The GOLD 2023 and 2024 reports recommend that health professionals consider triple therapy (TT) entailing combined use of a long-acting β 2 agonist (LABA), a long-acting muscarinic antagonist (LAMA), ...
An analysis of adoption of and adherence to chronic obstructive pulmonary disease (COPD) Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines in the primary care setting unearthed ...
For the first time, the revised GOLD Guidelines published in 2011 2 suggest a combined assessment of symptoms, the degree of airflow limitation as measured by spirometry, and the risk of future ...
—The 2019 GOLD guidelines emphasize the need for separate strategies for initial and follow-up pharmacotherapy and the importance of using of eosinophil counts to decide about inhaled corticosteroid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results